CARPL.ai
CARPL.ai operates an FDA 510(k) cleared enterprise imaging AI platform that enables healthcare providers to discover, validate, test, and deploy 300+ third-party radiology AI applications through a single integration pipeline. It serves hospitals, health systems, teleradiology providers, and AI vendors across the US, Brazil, Singapore, Australia, India, and the UK/Ireland.
- Company typePrivate
- Founded2018
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What CARPL.ai does
CARPL.ai is a private radiology AI platform company founded in 2018 and headquartered in San Francisco, California, with an operating entity (CARPL.AI Pvt Ltd) in New Delhi, India and a legal registration in Cupertino. The company operates an FDA 510(k) cleared enterprise imaging AI platform that aggregates third-party radiology AI applications and provides a single integration pipeline for healthcare providers to discover, validate, test, and deploy medical imaging AI solutions. Its core products include a Universal AI Viewer (infrastructure-agnostic, on-premise or cloud-deployable), an AI Marketplace positioned as the world's largest radiology AI marketplace with 300+ applications from 100+ vendors, and a proprietary Validation & Testing Module that produces single-click performance reports with AUC-ROC curves, confusion matrices, and drift detection. The platform supports both on-premise and cloud deployments, integrates with major PACS and RIS systems, and includes workflow features such as intelligent triaging, urgency flagging, and report auto-population.
The revenue model combines enterprise platform licensing (subscription-based, quote-driven) with potential marketplace commission from AI vendors commercializing through CARPL's deployed base. Go-to-market relies on direct enterprise sales to large healthcare systems, embedded distribution through PACS vendor partnerships (Fujifilm, Agfa, Intelerad, Ramsoft, Adva PACS, PaxeraHealth, Philips), and channel partners such as Medica Group and NTT DATA. Named customers span more than 15 enterprise logos across the United States (Mass General, University Hospitals Cleveland, RadNet/DeepHealth), Brazil (Fleury, Einstein Hospital Israelita, FIDI), Singapore (Synapxe, Tan Tock Seng, Changi General), Australia (I-MED, Qscan), India (AIIMS), and the UK/Ireland (Royal Marsden, Medica NHS Trusts). The company employs 11-50 people and has raised $6 million in seed funding led by Stellaris Venture Partners in February 2024, with a potential $5 million investment from the IFC reportedly in consideration in February 2026.
CARPL.ai firmographics
Firmographics- Name
- CARPL.ai
- Legal name
- Carpl.AI, Inc.
- Website
- https://carpl.ai
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CARPL.ai operates an FDA 510(k) cleared enterprise imaging AI platform that enables healthcare providers to discover, validate, test, and deploy 300+ third-party radiology AI applications through a single integration pipeline. It serves hospitals, health systems, teleradiology providers, and AI vendors across the US, Brazil, Singapore, Australia, India, and the UK/Ireland.
- Ownership category
- akta.pro rank
CARPL.ai industry classification
Industry- Product category
- Radiology AI Platform
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
- akta.pro secondary industries
- End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA), AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety) (HDAEANAF)
Keywords
Where CARPL.ai is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
CARPL.ai business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Enterprise Platform Licensing: Subscription-based licensing model for enterprise healthcare organizations to access the CARPL platform including AI marketplace, universal viewer, validation tools, and deployment capabilities. Provides single window access to discover, test, and deploy world-class medical imaging AI solutions.
- AI Marketplace Commission: CARPL serves as a marketplace for AI developers to commercialize their radiology AI solutions, potentially generating commission or transaction fees from AI vendors accessing the deployment base and user-base through single technical integration.
Distribution channels4 records
Marketing channels9 records
CARPL.ai product offering
Product offeringCore offering
CARPL.ai operates an FDA 510(k) cleared enterprise platform for the discovery, exploration, validation, and deployment of medical imaging AI. It combines a marketplace of 300+ third-party radiology AI applications from 100+ vendors with a universal AI viewer, pre-deployment validation tools, post-deployment monitoring, and infrastructure-agnostic deployment (on-premise or cloud) with PACS/RIS interoperability.
Product overview
CARPL.ai offers a unified radiology AI platform consisting of three interconnected core products: the AI Marketplace (offering 300+ applications from 100+ vendors), the Enterprise AI Platform (FDA 510(k) cleared, providing pre-deployment validation and post-deployment monitoring), and the Universal AI Viewer (providing a standardized interface across all AI outputs). The platform enables healthcare providers to discover, test, validate, and deploy AI solutions through a single integration point, supporting both cloud and on-premise deployments.
Differentiator
Problem solved
Functional benefit
Brands
- Women in AI Community: A global community dedicated to women in AI, promoting learning, creativity, and purpose-driven impact in healthcare technology.
Products and services
- Universal AI Viewer
Quantifiable outcome
- 30% acceleration in MSK x-ray interpretation at University Hospitals Cleveland
- +5 more outcomes
Companies that use CARPL.ai
Customer profileNamed customers17 records
Segments5 records
Ideal customer profiles4 records
CARPL.ai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability10 records
Feature6 records
CARPL.ai partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and strategic.
- EnliticcorePartnership to improve AI validation workflows for imaging customers through Enlitic's Ensight platform which structures and normalizes imaging data. Collaboration addresses data fragmentation in healthcare organizations, a key barrier to AI adoption in radiology, enabling faster identification and preparation of imaging studies for evaluation. Both companies aim to accelerate the path from AI exploration to real-world deployment in healthcare settings.
- NTT DATAstrategicNTT DATA partnered with The Royal Marsden NHS Foundation Trust and CARPL.ai to build AI-powered radiology service for brain tumour care. NTT DATA provides infrastructure and implementation services while CARPL provides the AI platform layer.
- Royal Marsden NHS Foundation TruststrategicUK's leading cancer center built AI-powered radiology service with NTT DATA and CARPL.ai for brain tumour care. Represents flagship use case for combining sovereign AI compute with governed health data to achieve better patient outcomes.
- Medica GroupcoreCARPL partnered with Medica Group to deploy its radiology AI marketplace and enterprise platform for teleradiology services across NHS Trusts in the UK and Ireland. Platform provides access to more than 200 licensed and validated AI tools, with Radiobotics' RBfracture among the first deployed for high-volume fracture detection processing up to 2,500 examinations per day. Partnership marks significant shift in how AI is validated and embedded into live clinical workflows at a national level.
- Vesta TeleradiologycoreVesta Teleradiology showcased AI-powered radiology workflow innovations at RSNA 2025 including new collaborations with Qure.ai, CARPL.ai, RadPair, and SimpliRad. Vesta integrated third-party AI technologies and internal platforms to improve radiology reporting, workflow, accuracy, and operational efficiency.
- DeepHealth (RadNet subsidiary)coreDeepHealth leverages strategic collaborations with TeraRecon and CARPL.ai to scale deployment. DeepHealth's Diagnostic Suite and SmartMammo solutions deployed in NHS England Lung Cancer Screening Program where 76% of detected cancers were caught at earlier stages. CARPL chosen as AI platform partner due to technological and clinical prowess. DeepHealth's partnership with CARPL creates unique environment to dynamically run combination of models and monitor performance.
- PhilipscoreStrategic partnership with Philips for radiology AI integration. Integration of AI results into PACS increases workflow efficiency and potentially reduces turnaround times for thoracic care. Philips positions CARPL as potentially ideal platform for Philips customers.
- FujifilmstrategicPACS integration partnership enabling CARPL's AI capabilities to be accessed through Fujifilm's Synapse PACS system, providing seamless workflow for radiologists.
- Agfa HealthcarestrategicPACS integration partnership enabling interoperability between CARPL's AI platform and Agfa's radiology imaging systems.
- InteleradstrategicPACS integration partnership enabling CARPL's AI platform capabilities to be accessed through Intelerad's imaging workflow solutions.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
CARPL.ai competitors and assessment
Company assessmentDirect peers
- Blackford Analysis: Blackford Analysis provides a radiology AI orchestration and integration platform that lets hospitals deploy multiple third-party AI algorithms through a single workflow. It is the closest direct peer to CARPL's marketplace and orchestration proposition in radiology imaging.
- EnvoyAI (now Medimsight): Medimsight (formerly EnvoyAI) operates a marketplace and integration layer for radiology AI algorithms. Directly comparable to CARPL's AI marketplace and orchestration engine for hospitals.
- Enlitic: Enlitic provides an AI platform that structures and normalizes medical imaging data for downstream algorithm deployment, and is now a CARPL partner. It overlaps with CARPL's validation and data-preparation workflow and competes in adjacent parts of the imaging AI orchestration stack.
- TeraRecon: TeraRecon (now part of ConcertAI) offers advanced visualization and AI orchestration for radiology, including a multi-vendor AI algorithm marketplace integrated into its viewer. Competes directly with CARPL's universal viewer and orchestration capabilities.
- Nuance Precision Imaging Network (Microsoft): Microsoft's Nuance Precision Imaging Network is an AI marketplace that distributes radiology AI algorithms to healthcare providers via the Nuance PowerScribe/PowerConnect workflow. Directly competes with CARPL's marketplace distribution model in the US enterprise radiology segment.
Emerging players
- Qure.ai: Qure.ai develops radiology AI algorithms (head CT, chest X-ray, TB) and distributes through both its own channels and partnerships including CARPL's marketplace. Adjacent vendor that increasingly competes for hospital AI deployment budgets.
- Aidoc: Aidoc is a leading radiology AI vendor whose algorithms are available on CARPL's marketplace but which also offers its own aiOS orchestration platform. Represents both a marketplace vendor and a direct competing platform layer.
- DeepHealth (RadNet subsidiary): DeepHealth, the AI subsidiary of RadNet, both partners with CARPL and develops its own diagnostic AI suite (e.g., SmartMammo) deployed through similar PACS-integrated workflows. Part ally, part competitor in the radiology AI orchestration space.
Broad incumbents
- Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion and broader digital health orchestration capabilities across its imaging equipment portfolio. Competes with CARPL as an integrated vendor offering both modalities and AI deployment.
- GE Healthcare (Edison AI Platform): GE Healthcare's Edison AI platform aggregates imaging AI applications and serves as an orchestration layer within GE imaging equipment and PACS. As a broad incumbent, it competes with CARPL's marketplace approach via embedded distribution across GE's installed base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks6 records
Key highlights7 records
Customer concentration
CARPL.ai social profiles
Digital presenceCARPL.ai compliance and trust
Trust signalCompliance1 record
CARPL.ai financial estimates
Financial estimateRevenue estimate
Valuation estimate
CARPL.ai leadership team
Management profileNumber of profiles
Profiles6 records
CARPL.ai funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CARPL.ai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CARPL.ai
What does CARPL.ai do?
CARPL.ai operates an FDA 510(k) cleared enterprise platform for the discovery, exploration, validation, and deployment of medical imaging AI. It combines a marketplace of 300+ third-party radiology AI applications from 100+ vendors with a universal AI viewer, pre-deployment validation tools, post-deployment monitoring, and infrastructure-agnostic deployment (on-premise or cloud) with PACS/RIS interoperability.
Is CARPL.ai a public or private company?
CARPL.ai is a private company. It is classified as venture growth investor backed and is currently operating.
When was CARPL.ai founded?
CARPL.ai was founded in 2018. It employs 11 to 50 people.
Where is CARPL.ai based?
CARPL.ai is headquartered in San Francisco, United States, in the North America region.
How does CARPL.ai make money?
Two revenue lines are on record. Enterprise Platform Licensing is the primary driver. The others are AI Marketplace Commission.
Who are CARPL.ai's main competitors?
Direct peers on record are Blackford Analysis, EnvoyAI (now Medimsight), Enlitic, TeraRecon and Nuance Precision Imaging Network (Microsoft). Emerging players are Qure.ai, Aidoc and DeepHealth (RadNet subsidiary). Broad incumbents are Siemens Healthineers (AI-Rad Companion) and GE Healthcare (Edison AI Platform).
Does CARPL.ai have an API?
Yes. CARPL.ai provides an API for technical integration. The Terms of Use reference API usage, stating users 'use any method to extract data from these services, including web scraping, web harvesting, or web data extraction methods, other than as permitted through the API.' This indicates a formal API exists for authorized data access and integration.
What industry is CARPL.ai in?
CARPL.ai's product category is Radiology AI Platform. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management). Its NAICS code is 62151 and its SIC code is 7372.